Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial
Authors
Keywords
-
Journal
Diabetes Technology & Therapeutics
Volume -, Issue -, Pages -
Publisher
Mary Ann Liebert Inc
Online
2022-03-10
DOI
10.1089/dia.2021.0540
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longevity of the novel ConvaTec infusion set with Lantern technology
- (2021) Rayhan A. Lal et al. DIABETES OBESITY & METABOLISM
- The improved survival rate and cost-effectiveness of a 7-day continuous subcutaneous insulin infusion set
- (2021) Timothy Kwa et al. JOURNAL OF MEDICAL ECONOMICS
- A Prospective Study of Insulin Infusion Set Use for up to 7 Days: Early Replacement Reasons and Impact on Glycemic Control
- (2020) Delia Waldenmaier et al. Diabetes Technology & Therapeutics
- 997-P: Testing a Novel Infusion Set for Extended Wear Duration
- (2020) BRUCE A. BUCKINGHAM et al. DIABETES
- 1012-P: Study of Insulin Stability Impact on Pump Therapy: Test Model Development
- (2020) SARNATH CHATTARAJ et al. DIABETES
- 986-P: Assessment of Adhesive Patches for an Extended-Wear Infusion Set
- (2020) GINA ZHANG et al. DIABETES
- Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes
- (2019) Maria O. Christensen et al. Diabetes Technology & Therapeutics
- Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study
- (2018) Anna Korsgaard Berg et al. Diabetes Technology & Therapeutics
- Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Results of an online survey
- (2018) Nadine Taleb et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies
- (2016) Michael Gibney et al. Diabetes Technology & Therapeutics
- Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes
- (2016) Andrew W. Karlin et al. Diabetes Technology & Therapeutics
- Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
- (2016) Richard M. Bergenstal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Trial of Infusion Set Function: Steel Versus Teflon
- (2013) Parul J. Patel et al. Diabetes Technology & Therapeutics
- Nonmetabolic Complications of Continuous Subcutaneous Insulin Infusion: A Patient Survey
- (2013) John C. Pickup et al. Diabetes Technology & Therapeutics
- Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion
- (2009) Tina K. Thethi et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started